April 27, 2020 / 12:21 PM / a month ago

BRIEF-Horizon Therapeutics PLC Announces Availability Of PROCYSBI

April 27 (Reuters) - Horizon Therapeutics PLC:

* HORIZON THERAPEUTICS PLC ANNOUNCES AVAILABILITY OF PROCYSBI® (CYSTEAMINE BITARTRATE) DELAYED-RELEASE ORAL GRANULES IN PACKETS IN THE UNITED STATES

* HORIZON THERAPEUTICS PLC - IN UNITED STATES, PROCYSBI IS NOW AVAILABLE IN TWO FORMS: TEAR-OPEN PACKETS AND CAPSULES

* HORIZON THERAPEUTICS PLC - PROCYSBI CAPSULES WILL CONTINUE TO BE AVAILABLE IN 25 MG AND 75 MG DOSAGE STRENGTHS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below